Q2 2018 Holdings
Filed 2018-08-14 | 44 holdings | $446.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biomarin Pharmaceutical Inc(BMRN) | Common | 09061G101 | $152.9M | 1,622,770 | 34.3% |
| Ascendis Pharma(ASND) | Sponsored ADR | 04351P101 | $137.3M | 2,063,336 | 30.8% |
| Alnylam Pharmaceuticals Inc(ALNY) | Common | 02043Q107 | $69.0M | 700,100 | 15.5% |
| Argenx SE(ARGX) | Sponsored ADR | 04016X101 | $64.8M | 782,053 | 14.5% |
| Catalyst Pharmaceuticals Inc(CPRX) | Common | 14888U101 | $14.0M | 4,497,042 | 3.1% |
| Arrowhead Pharmaceuticals Inc(ARWR) | Common | 04280A100 | $6.1M | 450,000 | 1.4% |
| Immunomedics Inc(IMMU) | Common | 452907108 | $419.3K | 17,714,461 | 0.1% |
| Mirati Therapeutics Inc(MRTXEUR) | Common | 60468T105 | $236.5K | 4,798,101 | 0.1% |
| Amicus Therapeutics Inc(FOLD) | Common | 03152W109 | $146.3K | 9,369,150 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | Common | 558868105 | $136.9K | 489,536 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | Common | 803607100 | $126.8K | 958,928 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | Common | 462260100 | $104.7K | 8,177,720 | 0.0% |
| Horizon Pharma PLC | Common | G4617B105 | $92.6K | 5,593,683 | 0.0% |
| Endocyte Inc | Common | 29269A102 | $78.6K | 5,695,200 | 0.0% |
| PTC Therapeutics Inc(PTCT) | Common | 69366J200 | $77.4K | 2,294,877 | 0.0% |
| Spectrum Pharmaceuticals Inc | Common | 84763A108 | $71.7K | 3,419,818 | 0.0% |
| Zogenix Inc | Common | 98978L204 | $66.4K | 1,503,313 | 0.0% |
| TG Therapeutics Inc(TGTX) | Common | 88322Q108 | $65.1K | 4,950,031 | 0.0% |
| Puma Biotechnology Inc(PBYI) | Common | 74587V107 | $61.2K | 1,034,375 | 0.0% |
| Vanda Pharmaceuticals Inc(VNDA) | Common | 921659108 | $53.3K | 2,800,191 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | Common | 189464100 | $52.1K | 1,146,436 | 0.0% |
| Pacira Pharmaceuticals Inc(PCRX) | Common | 695127100 | $46.8K | 1,460,610 | 0.0% |
| Viking Therapeutics Inc(VKTX) | Common | 92686J106 | $42.4K | 4,471,300 | 0.0% |
| Assembly Biosciences Inc | Common | 045396108 | $37.8K | 963,427 | 0.0% |
| Medicines Co | Common | 584688105 | $35.3K | 961,574 | 0.0% |
| Tricida Inc(1T7) | Common | 89610F101 | $32.8K | 1,095,764 | 0.0% |
| Global Blood Therapeutics Inc | Common | 37890U108 | $31.7K | 700,548 | 0.0% |
| Teligent Inc | Common | 87960W104 | $18.3K | 5,299,431 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | Common | 23257D103 | $17.2K | 1,282,374 | 0.0% |
| Dermira Inc(DERMEUR) | Common | 24983L104 | $16.9K | 1,841,823 | 0.0% |
| Biodelivery Sciences Intl(BDSIUSD) | Common | 09060J106 | $16.0K | 5,437,779 | 0.0% |
| Sesen BIO Inc | Common | 817763105 | $13.3K | 6,800,000 | 0.0% |
| Intec Pharma LTD | Common | M53644106 | $11.3K | 2,570,705 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | Common | 98420N105 | $11.1K | 1,202,118 | 0.0% |
| Fennec Pharmaceuticals Inc(FENC) | Common | 31447P100 | $10.7K | 1,022,666 | 0.0% |
| Alimera Sciences Inc | Common | 016259103 | $6.1K | 6,241,581 | 0.0% |
| Oncosec Medical Inc | Common | 68234L207 | $5.5K | 4,007,696 | 0.0% |
| Spdr Series Trust - S&P Biotech(XBI)Put | ETF | 78464A870 | $5.3K | 1,750,000 | 0.0% |
| Avrobio Inc | Common | 05455M100 | $2.9K | 100,000 | 0.0% |
| Pernix Therapeutics Holdings Inc | Convertible Debt | 71426VAK4 | $2.6K | $6,000,000 | 0.0% |
| Oncobiologics Inc | Common | 68235M105 | $578 | 683,531 | 0.0% |
| Oncobiologics Inc - Warrant A | Warrant | 68235M113 | $12 | 233,333 | 0.0% |